Previous Section | Index | Home Page |
Mr. Dalyell: To ask the Secretary of State for Health if he will ensure that he receives a copy of the report from the Select Committee of the House of Lords on stem cell research as soon as it is published. [147608]
Yvette Cooper: Yes. We will work with the House of Lords Select Committee and will consider carefully its conclusions and any recommendations it may make.
Mr. Laurence Robertson: To ask the Secretary of State for Health how many specialist MS nurses there are in the UK; what plans he has to train more MS nurses; and if he will make a statement. [149196]
6 Feb 2001 : Column: 514W
Mr. Denham: Information on specialist multiple sclerosis nurses is not collected centrally. However, we understand that the MS Society has recently launched a £2 million fund to encourage the development of MS specialist nurse posts.
The development and funding of specialist nursing posts to treat specific conditions such as MS is for health authorities, in partnership with primary care groups/trusts and other local stakeholders, to determine.
Mr. Hoyle: To ask the Secretary of State for Health what financial support the Government have given to Derian House hospice and St. Catherine's hospice in Lancashire. [147332]
Yvette Cooper: During the year 2000-01, Derian House Hospice and St. Catherine's Hospice received funding totalling almost £500,000 from the South Lancashire and North West Lancashire Health Authorities.
Mrs. Brinton: To ask the Secretary of State for Health if he will make a statement on his plans for the treatment of Alzheimer's disease. [147350]
Mr. Hutton: Developing and improving support for people with Alzheimer's disease is a priority for us. NICE has recently recommended that donepezil, rivastigmine and galantamine should be made available in the NHS as one component of the management of those people with mild to moderate Alzheimer's disease. The forthcoming National Service Framework for Older People will, for the first time, set national standards and define service models for older people's health and social care, driving up the quality and reducing the variations of that care. The NSF will look at conditions that mainly affect older people, including dementia.